Table 1. Clinical and demographic charactheristics with and without NAFPD subjects.
| Variables | NAFPD absence (n = 49) | NAFPD presence (n = 54) | p value |
| Clinical and demographic charactheristics | |||
| Age, year | 49 ± 8 | 52 ± 10 | 0.131 |
| Gender, male, n (%) | 16 (33) | 22 (40) | 0.396 |
| Hypertension, n (%) | 19 (39) | 29 (54) | 0.129 |
| DM, n (%) | 11 (22) | 21 (39) | 0.112 |
| Dyslipidemia, n (%) | 21 (43) | 23 (43) | 0.978 |
| Current smoking, n (%) | 18 (37) | 11 (20) | 0.104 |
| Family history of CAD, n (%) | 2 (4) | 5 (9) | 0.285 |
| BMI (kg/m2) | 31.4 ± 4.5 | 33.1 ± 5.3 | 0.103 |
| HR (bpm) | 79 ± 14 | 78 ± 14 | 0.654 |
| SBP, mmHg | 120.4 ± 12.7 | 124.5 ± 16.5 | 0.367 |
| 120 (90-160) | 124 (100-180) | ||
| DBP, mmHg | 78.6 ± 8.9 | 81.3 ± 9.6 | 0.155 |
| 78 (60-100) | 81 (60-100) | ||
| Biochemical and hematological parameters | |||
| Serum glucose (mg/dL) | 116.6 ± 49.1 | 128.7 ± 45.7 | 0.02 |
| 117 (83-330) | 128 (86-292) | ||
| Serum creatinine (mg/dL) | 0.76 ± 0.15 | 0.82 ± 0.22 | 0.173 |
| ALT (IU/L) | 24.5 ± 11.4 | 35.8 ± 26.7 | 0.234 |
| 24.5 (9-63) | 35 (10-115) | ||
| LDL-c (mg/dL) | 152 ± 37 | 151 ± 38 | 0.904 |
| Triglyceride (mg/dL) | 189 ± 105 | 178 ± 83 | 0.623 |
| WBC (×109/L) | 7.32 ± 1.66 | 6.87 ± 1.31 | 0.247 |
| Hb (g/dL) | 13.6 ± 1.6 | 13.8 ± 1.6 | 0.570 |
| PLT (×109/L) | 249 ± 50 | 237 ± 57 | 0.324 |
ALT, alanin amino transferase; BMI, body mass index; CAD, coronary artery disease; DBP, diastolic blood pressure; DM, diabetes mellitus; Hb, hemoglobin; HR, heart rate; LDL-c, low-density lipoprotein cholesterol; NAFPD, non-alcoholic fatty pancreatic disease; PLT, platelet; SBP, systolic blood pressure; WBC, white blood cells.